In MS, visfatin enhances the inflammatory response by promoting the secretion of cytokines and modulating T and B lymphocyte function, contributing to the loss of immune tolerance and perpetuation of CNS autoimmunity [17]. The gene discussed is NAMPT; the disease is myeloid sarcoma.